Pan-Asia Catalysts/Events, Quiddity Advisors

David Blennerhassett

HK Type 4 license through Ballingal Investment Advisors Ltd. 

I'm a highly experienced sell-side analyst with in excess of 22 years of covering Asia Pacific equities, the past 19 years immersed in event strategies encompassing M&A risk arbitrage, directional long/short, stub trades and restructuring.  

My background also includes accountancy (liquidation/bankruptcy/receivership) earlier in my career and as a chief financial officer of a global commodity company based in the US and Mexico.

Pan-Asia Catalysts/Events

Asaleo (ASX: AHY): Essity's Revised Offer

Asaleo (ASX: AHY): Essity’s Offer Gets Up

Quiddity Advisors

Event-Driven

Swedish outfit <a href="https://www.smartkarma.com/entities/essity-ab" target="_blank" data-smartkarma-citation="entities:28203:1" rel="noopener">Essity AB (ESSITYB SS)</a> has made a conditional, non-binding A$1.26/share offer for the remaining 63.8% of <a href="https://www.smartkarma.com/entities/asaleo-care-ltd" target="_blank" data-smartkarma-citation="entities:19923:1" rel="noopener">Asaleo Care Ltd (AHY AU)</a> it does not already own, either by way of a Scheme or an off-market takeover.
Hygiene, personal care, and consumer tissue products producer Asaleo <a href="https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02320914-3A557776?access_token=83ff96335c2d45a094df02a206a39ff4" target="_blank" rel="noopener">said</a> the Offer price, a 24.7% premium to last close, reflected a low takeover premium to recent market prices and was highly opportunistic in timing.
However, Asaleo added it was still in the early stages of assessing the proposal.
It is understood this is Essity's initial Offer, suggesting there is scope for a bump.
More below the fold.

Swedish outfit Essity AB (ESSITYB SS) has made a conditional, non-binding A$1.26/share offer for the remaining 63.8% of Asaleo Care Ltd (AHY AU) it does not already own, either by way of a Scheme or an off-market takeover.
Hygiene, personal care, and consumer tissue products producer Asaleo said the Offer price, a 24.7% premium to last close, reflected a low takeover premium to recent market prices and was highly opportunistic in timing.
However, Asaleo added it was still in the early stages of assessing the proposal.
It is understood this is Essity's initial Offer, suggesting there is scope for a bump.
More below the fold.

Asaleo Care Ltd

Asaleo (ASX: AHY)/Essity: Bottom Feeders